Why Are These Two Overlooked Stocks Catching Macquarie’s Attention?

4 min read | June 04, 2026 01:36 PM AEST | By Sam

Highlights

  • Macquarie has identified two companies it believes could deliver substantial upside from current levels.
  • Pexa Group continues to benefit from growing digital property settlement activity across Australia and the United Kingdom.
  • Ebos Group is drawing attention for its healthcare distribution network and defensive business profile.

Pexa and Ebos have emerged as companies attracting broker attention due to digital transformation, healthcare demand and strong market positions across their respective industries.

Australian investors continue searching for companies capable of delivering growth despite ongoing market uncertainty. While several sectors have faced volatility in recent months, some analysts believe select businesses remain well positioned due to their market leadership, industry exposure and long-term growth strategies. Among the latest names attracting broker attention are Pexa Group (ASX:PXA) and Ebos Group (ASX:EBO), two companies operating in very different sectors but sharing a common theme of strong market positioning and operational resilience. Their latest developments have generated renewed discussion across the broader ASX 200.

Pexa Continues Expanding Its Digital Property Platform

Pexa has established itself as a leading provider of digital property settlement services, transforming how property transactions are processed across Australia.

The company recently highlighted continued transaction growth across its Australian operations while maintaining momentum in the United Kingdom. Its platform plays an increasingly important role in digitising property settlements, helping financial institutions, legal professionals and property participants streamline transaction processes.

Market attention remains focused on the potential for broader adoption among major lenders and institutions. Additional participation from large financial organisations could further strengthen the platform's position within the property ecosystem.

As a growing participant within the ASX Technology Stocks category, Pexa continues to benefit from long-term digital transformation trends occurring across financial and property services industries.

Property Market Activity Remains A Key Driver

Despite periods of economic uncertainty, property transaction activity has remained relatively resilient.

Pexa's latest update highlighted ongoing transaction processing growth, supported by continued adoption of digital settlement solutions. The business also continues investing in operational efficiency while expanding its service offering across multiple markets.

The company’s growing role within property infrastructure has helped establish a business model that extends beyond traditional technology services and into critical transaction processing activities.

Why Ebos Is Drawing Fresh Interest

Ebos operates one of the largest healthcare and pharmaceutical distribution networks across Australia and New Zealand.

The company plays an important role in supplying healthcare products, medical equipment and pharmaceutical services to healthcare providers, pharmacies and consumers. This positioning provides exposure to healthcare demand trends that are often viewed as relatively defensive during periods of economic uncertainty.

Recent market attention has focused on industry agreements and healthcare distribution arrangements that may support the company's operational outlook.

As one of the established participants within the ASX Healthcare Stocks sector, Ebos benefits from broad exposure across multiple healthcare segments and essential service categories.

Defensive Qualities Continue To Appeal

Healthcare distribution businesses often attract attention during periods of market volatility because demand for healthcare products tends to remain relatively stable regardless of broader economic conditions.

This characteristic has helped position Ebos as a company capable of maintaining operational activity across varying market environments.

The company’s diversified healthcare footprint also provides exposure to several growth areas within healthcare delivery and pharmaceutical services.

Market Focus Shifts Towards Quality Businesses

The broader market environment continues encouraging investors to focus on companies with strong competitive positions and established revenue streams.

Businesses operating within sectors supported by structural growth trends often attract additional attention during periods when market sentiment becomes more selective.

For technology companies such as Pexa, digitisation remains a key long-term growth theme. For healthcare-focused businesses such as Ebos, demographic trends and healthcare demand continue supporting industry activity.

What Could Investors Watch Next?

Future updates from both companies are likely to remain closely monitored by the market.

For Pexa, continued platform adoption, transaction growth and expansion within the United Kingdom remain important areas of focus. For Ebos, healthcare demand trends, operational execution and distribution network performance are expected to remain key considerations.

While both companies operate in different industries, their ability to maintain market leadership and execute strategic initiatives will likely continue shaping market sentiment.

Frequently Asked Questions

  • What does Pexa do?
    Pexa operates a digital property settlement platform that facilitates electronic property transactions and settlements.
  • Why is Ebos considered a healthcare company?
    Ebos distributes pharmaceuticals, healthcare products and medical supplies across Australia and New Zealand.
  • Which sectors do these companies belong to?
    Pexa operates within technology-focused services, while Ebos is part of the healthcare and pharmaceutical distribution sector.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.